Clinical Trials Browser

Completed × Axitinib × Dermatologic × Clear all

NCT01321437 2021-01-20

Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma

Phase 2 Completed

11 enrolled 12 charts

Melanoma

NCT01174238 2018-06-08

A Two Arm Trial of Axitinib and Carboplatin/Paclitaxel in Melanoma

Phase 2 Completed

40 enrolled 10 charts

Melanoma

NCT00094107 2012-06-26

Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma

Phase 2 Completed

32 enrolled 9 charts

Melanoma, Skin Neoplasms